Malabsorption panel

Available exclusively at Mayo Clinic Laboratories and appropriate for all ages, our malabsorption evaluation panel includes assays carefully selected for their ability to quickly eliminate differential diagnosis and target the root cause of the gastrointestinal distress. Designed to expedite answers, our panel minimizes stress and optimizes patient outcomes.

Key testing

• MALP | Malabsorption Evaluation Panel, Feces
  • Particularly useful for pediatric patients.
  • Simplifies the ordering process.
  • Requires a single stool sample.
  • Quickly rules in or out numerous causes of GI conditions.
  • Facilitates patient compliance.

Testing panel includes

• A1AF | Alpha-1-Antitrypsin, Random, Feces
  • Tests for protein loss through evaluation of alpha-1-antitrypsin, a protein largely resistant to breakdown and a good marker of how much protein is lost in the stool.
• CALPR | Calprotectin, Feces
  • Tests for mucosal and intestinal inflammation through evaluation of the inflammatory marker calprotectin.
• ELASF | Pancreatic Elastase, Feces
  • Evaluates for the pancreatic elastase enzyme, which indicates the body’s ability to digest certain proteins and carbohydrates.
• UREDF | Reducing Substance, Feces
  • Tests for carbohydrate malabsorption, or malabsorption of glucose or fructose.

---

Disaccharidase activity

We use a panel-based approach to evaluate patients for disaccharidase deficiency when serological testing, imaging studies, and breath testing are negative.

Key testing

• DSAC | Disaccharidase Activity Panel, Tissue

Advantages

• Examines tissue samples, taken as part of endoscopy, to gain quantitative values of lactase, sucrase, maltase, palatinase, and glucoamylase.
• Test reports include clinical results interpretation.